Your browser doesn't support javascript.
loading
Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer.
Vidula, Neelima; Dubash, Taronish; Lawrence, Michael S; Simoneau, Antoine; Niemierko, Andrzej; Blouch, Erica; Nagy, Becky; Roh, Whijae; Chirn, Brian; Reeves, Brittany A; Malvarosa, Giuliana; Lennerz, Jochen; Isakoff, Steven J; Juric, Dejan; Micalizzi, Douglas; Wander, Seth; Spring, Laura; Moy, Beverly; Shannon, Kristen; Younger, Jerry; Lanman, Richard; Toner, Mehmet; Iafrate, A John; Getz, Gad; Zou, Lee; Ellisen, Leif W; Maheswaran, Shyamala; Haber, Daniel A; Bardia, Aditya.
Affiliation
  • Vidula N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. nvidula@mgh.harvard.edu.
  • Dubash T; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.
  • Lawrence MS; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Simoneau A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.
  • Niemierko A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Blouch E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Nagy B; Guardant Health, Inc., Redwood City, California.
  • Roh W; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Chirn B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.
  • Reeves BA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.
  • Malvarosa G; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Lennerz J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Isakoff SJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Juric D; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Micalizzi D; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Wander S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Spring L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Moy B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Shannon K; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Younger J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Lanman R; Guardant Health, Inc., Redwood City, California.
  • Toner M; Center for Engineering in Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Iafrate AJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Getz G; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Zou L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Ellisen LW; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Maheswaran S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Haber DA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
Clin Cancer Res ; 26(18): 4852-4862, 2020 09 15.
Article in En | MEDLINE | ID: mdl-32571788
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / BRCA1 Protein / BRCA2 Protein / Circulating Tumor DNA Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / BRCA1 Protein / BRCA2 Protein / Circulating Tumor DNA Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Year: 2020 Type: Article